Laura A. Knight

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

Eileen E. Parkes, Steven M. Walker, Laura E. Taggart et al. · JNCI Journal of the National Cancer Institute · 2016 · 447 citations · Full text

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy

Suneil Jain, C. Lyons, Steven M. Walker et al. · Annals of Oncology · 2017 · 128 citations · Full text

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis

Shannon Telesco, Carrie Brodmerkel, Hongyan Zhang et al. · Gastroenterology · 2018 · 68 citations · Full text

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

Priyanka Sharma, William E. Barlow, Andrew K. Godwin et al. · Journal of Clinical Oncology · 2019 · 48 citations · Full text

High <i>EMSY</i> expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

Robert L. Hollis, Michael Churchman, Caroline O. Michie et al. · Cancer · 2019 · 40 citations · Full text